162 related articles for article (PubMed ID: 37161965)
1. T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases.
Høye E; Dagenborg VJ; Torgunrud A; Lund-Andersen C; Fretland ÅA; Lorenz S; Edwin B; Hovig E; Fromm B; Inderberg EM; Greiff V; Ree AH; Flatmark K
Gigascience; 2022 Dec; 12():. PubMed ID: 37161965
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases.
Dagenborg VJ; Marshall SE; Yaqub S; Grzyb K; Boye K; Lund-Iversen M; Høye E; Berstad AE; Fretland ÅA; Edwin B; Ree AH; Flatmark K
Cancer Biol Ther; 2020 May; 21(5):432-440. PubMed ID: 32098573
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
4. Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal Cancer.
Xu M; Tsunedomi R; Kiyotani K; Tomochika S; Furuya K; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Anticancer Res; 2023 Feb; 43(2):613-620. PubMed ID: 36697107
[TBL] [Abstract][Full Text] [Related]
5. Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases.
Pietrantonio F; Mazzaferro V; Miceli R; Cotsoglou C; Melotti F; Fanetti G; Perrone F; Biondani P; Muscarà C; Di Bartolomeo M; Coppa J; Maggi C; Milione M; Tamborini E; de Braud F
Med Oncol; 2015 Jul; 32(7):182. PubMed ID: 26003673
[TBL] [Abstract][Full Text] [Related]
6. Human urothelial bladder cancer generates a clonal immune response: The results of T-cell receptor sequencing.
Sankin A; Chand D; Schoenberg M; Zang X
Urol Oncol; 2019 Nov; 37(11):810.e1-810.e5. PubMed ID: 31103336
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor repertoire in colorectal adenocarcinoma patients with hepatic metastases and its changes induced by preoperative adjuvant interleukin-2 therapy.
Savelieva E; Farace F; Angevin E; Elias D; Escudier B; Duvillard P; Hercend T; Triebel F
J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):66-76. PubMed ID: 7521724
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.
Chen YT; Hsu HC; Lee YS; Liu H; Tan BC; Chin CY; Chang IY; Yang CY
Front Immunol; 2021; 12():743448. PubMed ID: 35095836
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy.
Casarrubios M; Cruz-Bermúdez A; Nadal E; Insa A; García Campelo MDR; Lázaro M; Dómine M; Majem M; Rodríguez-Abreu D; Martínez-Martí A; de Castro-Carpeño J; Cobo M; López-Vivanco G; Del Barco E; Bernabé Caro R; Viñolas N; Barneto Aranda I; Viteri S; Massuti B; Barquín M; Laza-Briviesca R; Sierra-Rodero B; Parra ER; Sanchez-Espiridion B; Rocha P; Kadara H; Wistuba II; Romero A; Calvo V; Provencio M
Clin Cancer Res; 2021 Nov; 27(21):5878-5890. PubMed ID: 34376534
[TBL] [Abstract][Full Text] [Related]
10. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.
Snyder A; Nathanson T; Funt SA; Ahuja A; Buros Novik J; Hellmann MD; Chang E; Aksoy BA; Al-Ahmadie H; Yusko E; Vignali M; Benzeno S; Boyd M; Moran M; Iyer G; Robins HS; Mardis ER; Merghoub T; Hammerbacher J; Rosenberg JE; Bajorin DF
PLoS Med; 2017 May; 14(5):e1002309. PubMed ID: 28552987
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.
Aschauer C; Jelencsics K; Hu K; Heinzel A; Vetter J; Fraunhofer T; Schaller S; Winkler S; Pimenov L; Gualdoni GA; Eder M; Kainz A; Regele H; Reindl-Schwaighofer R; Oberbauer R
BMC Nephrol; 2019 Sep; 20(1):346. PubMed ID: 31477052
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic CD69
Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
[TBL] [Abstract][Full Text] [Related]
13. TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer.
Looney TJ; Topacio-Hall D; Lowman G; Conroy J; Morrison C; Oh D; Fong L; Zhang L
Front Immunol; 2019; 10():2985. PubMed ID: 31993050
[TBL] [Abstract][Full Text] [Related]
14. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Sabanathan D; Eslick GD; Shannon J
Clin Colorectal Cancer; 2016 Dec; 15(4):e141-e147. PubMed ID: 27174607
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma.
Shi L; Zhang Y; Feng L; Wang L; Rong W; Wu F; Wu J; Zhang K; Cheng S
Oncotarget; 2017 May; 8(21):34844-34857. PubMed ID: 28422742
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
17. A
Nygaard V; Ree AH; Dagenborg VJ; Børresen-Dale AL; Edwin B; Fretland ÅA; Grzyb K; Haugen MH; Mælandsmo GM; Flatmark K
Cancer Res Commun; 2023 Feb; 3(2):235-244. PubMed ID: 36968142
[TBL] [Abstract][Full Text] [Related]
18. Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy.
Abed A; Beasley AB; Reid AL; Law N; Calapre L; Millward M; Lo J; Gray ES
ESMO Open; 2023 Dec; 8(6):102066. PubMed ID: 37995426
[TBL] [Abstract][Full Text] [Related]
19. Clonality of CD4
Arakawa A; Vollmer S; Tietze J; Galinski A; Heppt MV; Bürdek M; Berking C; Prinz JC
Front Immunol; 2019; 10():1336. PubMed ID: 31275310
[TBL] [Abstract][Full Text] [Related]
20. Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
Park JH; Jang M; Tarhan YE; Katagiri T; Sasa M; Miyoshi Y; Kalari KR; Suman VJ; Weinshilboum R; Wang L; Boughey JC; Goetz MP; Nakamura Y
Int J Oncol; 2016 Aug; 49(2):471-8. PubMed ID: 27278091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
